Practice Guideline for Adult Antibiotic Prophylaxis During Vascular and Interventional Radiology Procedures
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Management of Liver Complications in Sickle Cell Disease
| MANAGEMENT OF SICKLE CELL DISEASE COMPLICATIONS BEYOND ACUTE CHEST | Management of liver complications in sickle cell disease Abid R. Suddle Institute of Liver Studies, King’s College Hospital, London, United Kingdom Downloaded from https://ashpublications.org/hematology/article-pdf/2019/1/345/1546038/hem2019000037c.pdf by DEUSCHE ZENTRALBIBLIOTHEK FUER MEDIZIN user on 24 December 2019 Liver disease is an important cause of morbidity and mortality in patients with sickle cell disease (SCD). Despite this, the natural history of liver disease is not well characterized and the evidence basis for specific therapeutic intervention is not robust. The spectrum of clinical liver disease encountered includes asymptomatic abnormalities of liver function; acute deteriorations in liver function, sometimes with a dramatic clinical phenotype; and decompensated chronic liver disease. In this paper, the pathophysiology and clinical presentation of patients with acute and chronic liver disease will be outlined. Advice will be given regarding initial assessment and investigation. The evidence for specific medical and surgical interventions will be reviewed, and management recommendations made for each specific clinical presen- tation. The potential role for liver transplantation will be considered in detail. S (HbS) fraction was 80%. The patient was managed as having an Learning Objectives acute sickle liver in the context of an acute vaso-occlusive crisis. • Gain an understanding of the wide variety of liver pathology Treatment included IV fluids, antibiotics, analgesia, and exchange and disease encountered in patients with SCD blood transfusion (EBT) with the aim of reducing the HbS fraction • Develop a logical approach to evaluate liver dysfunction and to ,30% to 40%. With this regimen, symptoms and acute liver dys- disease in patients with SCD function resolved, but bilirubin did not return to the preepisode baseline. -
Which Antibiotic Prophylaxis Guidelines for Infective Endocarditis Should Canadian Dentists Follow?
Debate & O P I N I O N Which Antibiotic Prophylaxis Guidelines for Infective Endocarditis Should Canadian Dentists Follow? Contact Author Herve Y. Sroussi, DMD, PhD; Ashwin R. Prabhu, BDS; Dr. Epstein Joel B. Epstein, DMD, MSD, FRCD(C) Email: [email protected] For citation purposes, the electronic version is the definitive version of this article: www.cda-adc.ca/jcda/vol-73/issue-5/401.html ental providers must keep up to date 2 weeks following a procedure, dental proced- with antibiotic prophylaxis guidelines ures conducted even months earlier may be Dfor infectious endocarditis (IE) as these questioned as causative of IE.4 Furthermore, guidelines represent standards of care and periodontal and dental disease increase the determine medicolegal standards. A survey risk of bacteremia with activities of daily of Canadian dentists revealed that practi- living and may more commonly cause bac- tioners tend to employ antibiotic prophylaxis teremia; therefore, good oral care is of para- according to the guidelines in place at the mount importance in patients with conditions time of their graduation from dental school that place them at risk for IE. — guidelines that often do not meet the cur- To reduce the risk of IE following dental rent standards,1 as both the American Heart procedures, prophylactic measures have Association (AHA)2 and the British Society been developed by experts in the fields of for Antimicrobial Chemotherapy (BSAC)3 have microbiology, epidemiology, cardiology and currently updated their recommendations. dentistry. The principle preventive measure Host factors that increase the risk of IE recommended is the use of prophylactic anti- include specific cardiac abnormalities, a biotics before certain dental procedures in pa- previous episode of IE and the extent of the tients identified as at risk. -
Antibiotic Prophylaxis for Surgical Procedures
Summary and Conclusions Antibiotic Prophylaxis for Surgical Procedures A Systematic Review Swedish Council on Health Technology Assessment SBU Board of Directors and Scientific Advisory Committee Secretariat MÅNS ROSÉN Executive Director, SBU Board of Directors NINA REHNQVIST BJÖRN KLINGE MARGARETA TROEIN Karolinska Institute, Solna Karolinska Institute, TÖLLBORN (Chair) Solna The Swedish Society of Medicine EVA NILSSON BÅGENHOLM MÅNS ROSÉN The Swedish Medical SBU MATS ULFENDAHL Association The Swedish Research KARIN STRANDBERG NÖJD Council HÅKAN CEDER The Swedish Association The National Board of Local Authorities and SABINA WIKGREN ORSTAM of Health and Welfare Regions The Swedish Association ANNA-KARIN EKLUND HÅKAN SÖRMAN of Local Authorities and Swedish Association The Swedish Association Regions of Health Professionals of Local Authorities and Regions Scientific Advisory Committee DAVID BERGQVIST MATS G HANSSON ULF NÄSLUND Uppsala University Uppsala University Norrland University Hospital (Chair) Hospital, Umeå MIKAEL HELLSTRÖM BJÖRN BEERMANN Sahlgrenska Hospital, JOAKIM RAMSBERG Medical Products Agency, Gothenburg i3 Innovus, Stockholm Uppsala MARGARETA MÖLLER BO RUNESON CHRISTINA BERGH University Hospital, Karolinska Institute, Sahlgrenska Hospital, Örebro Solna Gothenburg JÖRGEN NORDENSTRÖM GUNNEL SVENSÄTER CECILIA BJÖRKELUND Karolinska University Malmö University Gothenburg University Hospital, Solna ANIA WILLMAN 2 SBU'S SUMMARY AND CONCLUSIONS SÖLVE ELMSTÅHL OLOF NYRÉN Blekinge Institute of University Hospital, Karolinska Institute, -
Guideline on Antibiotic Prophylaxis for Dental Patients at Risk for Infection
american academy of pediatric dentistry Guideline on Antibiotic Prophylaxis for Dental Patients at Risk for Infection Originating Committee clinical affairs committee Review Council council on clinical affairs Adopted 1990 Revised 1991, 1997, 1999, 2002, 2005, 2007, 2008 Purpose may be at increased risk. If a patient reports a syndrome or The American Academy of Pediatric Dentistry (AAPD) recog- medical condition with which the practitioner is not familiar, nizes that numerous medical conditions predispose patients it is appropriate to contact the child’s physician to determine to bacteremia-induced infections. Because it is not possible to susceptibility to bacteremia-induced infections. predict when a susceptible patient will develop an infection, In 2007, the American Heart Association (AHA) released its prophylactic antibiotics are recommended when these patients newly revised guidelines for the prevention of IE and reducing undergo procedures most likely to produce bacteremia. This the risk for producing resistant strains of bacteria.3 The 2007 guideline is intended to help practitioners make appropriate revision was based on relevant literature and studies, in con- decisions regarding antibiotic prophylaxis for dental patients sultation with national and international experts. The AAPD, at risk. acknowledging the AHA’s expertise and efforts to produce evidenced-based recommendations, continues to endorse the Methods AHA guideline for antibiotic prophylaxis, now entitled “Pre- This guideline is based on a review of current dental and medical vention of Infective Endocarditis”. literature pertaining to postprocedural bacteremia-induced The primary reasons for the revision include: infections. A MEDLINE search was performed using the key- • “IE is much more likely to result from frequent exposure words “infective endocarditis” (IE), “bacteremia”, “antibiotic to random bacteremias associated with daily activities than prophylaxis”, and “dental infection”. -
Antibiotic Prophylaxis for GI Endoscopy
GUIDELINE Antibiotic prophylaxis for GI endoscopy This is one of a series of statements discussing the use of procedure. Endoscopy-related bacteremia carries a small GI endoscopy in common clinical situations. The Stan- risk of localization of infection in remote tissues (ie, infec- dards of Practice Committee of the American Society for tive endocarditis [IE]). Endoscopy also may result in local Gastrointestinal Endoscopy (ASGE) prepared this docu- infections in which a typically sterile space or tissue is ment, and it updates a previously issued document on breached and contaminated by an endoscopic accessory this topic.1 In preparing this guideline, MEDLINE and or by contrast material injection. This document is an up- PubMed databases were used to search for publications date of the prior ASGE document on antibiotic prophylaxis between January 1975 and December 2013 pertaining for GI endoscopy,1 discusses infectious adverse events to this topic. The search was supplemented by accessing related to endoscopy, and provides recommendations for the “related articles” feature of PubMed, with articles periprocedural antibiotic therapy. identified on MEDLINE and PubMed as the references. Additional references were obtained from the bibliogra- phies of the identified articles and from recommenda- BACTEREMIA ASSOCIATED WITH tions of expert consultants. When few or no data were ENDOSCOPIC PROCEDURES available from well-designed prospective trials, emphasis was given to results from large series and reports from Bacteremia can occur after endoscopic procedures and has been advocated as a surrogate marker for IE risk. How- recognized experts. Weaker recommendations are indi- fi cated by phrases such as “We suggest.” whereas stronger ever, clinically signi cant infections are extremely rare. -
Antibiotic Prophylaxis for Surgical Procedures: a Scoping Review
01 Pan American Journal Review of Public Health 02 03 04 05 06 Antibiotic prophylaxis for surgical procedures: 07 08 a scoping review 09 10 11 1,2 2 1 2 2 Eva Brocard, Ludovic Reveiz, Jean-Philippe Régnaux, Veronica Abdala, Pilar Ramón-Pardo, 12 and Ana del Rio Bueno2 13 14 15 16 Suggested citation Brocard E, Reveiz L, Régnaux J-P, Abdala V, Ramón-Pardo P, del Rio Bueno A. Antibiotic prophylaxis for surgical procedures: 17 a scoping review. Rev Panam Salud Publica. 2021;45:e62. https://doi.org/10.26633/RPSP.2021.62 18 19 20 21 ABSTRACT Objectives. To map the current evidence on surgical antibiotic prophylaxis (SAP) administration and identify 22 knowledge gaps in the literature available in this field. 23 Methods. The PubMed, Cochrane Library, Epistemonikos, and Health Systems Evidence databases were 24 searched from January 2015 to March 2020 for systematic reviews published in English, French, Portuguese, 25 and Spanish. 26 Results. Eighty-three systematic reviews were included, the quality of the reviews was assessed using 27 AMSTAR 2, and data were extracted for all primary outcomes. Perioperative antibiotic administration, the use 28 of first generation cephalosporins, and surgical site infection (SSI) were the most commonly reported for timing 29 of antibiotic administration, drug class, and primary outcome, respectively. Findings showed that, overall, SAP 30 may reduce SSIs compared with a placebo or with no SAP. Results suggested that intraoperative SAP may 31 lower SSI, while postoperative SAP did not show a statistically significant difference. 32 Conclusions. Findings have confirmed the role of SAP in reducing postoperative SSI across various surgeries 33 and do not support the use of antibiotics after surgery to prevent infections. -
Accuracy and Reliability of Palpation and Percussion for Detecting Hepatomegaly: a Rural Hospital-Based Study
Accuracy and reliability of palpation and percussion for detecting hepatomegaly: a rural hospital-based study Rajnish Joshi, Amandeep Singh, Namita Jajoo, Madhukar Pai,* S P Kalantri Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442 102, Maharashtra; and *Division of Epidemiology, University of California at Berkeley, Berkeley, CA 94720, USA Background: Palpation and percussion are standard Although many physicians believe that physical bedside techniques used to diagnose hepatomegaly. examination can accurately identify hepatomegaly, some Ultrasonography is a noninvasive and accurate method published reports suggest that physical signs lack accu- for measurement of liver size, but many patients in racy and reliability.1,2,3 To our knowledge, no study from developing countries have limited access to it. We India has evaluated the accuracy of physical examina- compared the accuracy of palpation and percussion tion in the assessment of enlarged liver. We conducted in a rural population in central India, using this study to determine how accurately doctors can ultrasonography as a reference standard. Methods: distinguish an enlarged liver from a normal sized one, The study design was a blinded, cross-sectional analysis and how often they agree with one another while as- of a hospital-based case series. Three physicians, sessing liver size. blind to clinical data and to each others results, independently used palpation and percussion to detect Methods hepatomegaly. Diagnostic accuracy was measured by We enrolled consecutive patients admitted to the Medi- computing sensitivity, specificity, and likelihood ratio cine wards between February 1 and 15, 2003. Patients values. Inter-physician agreement was assessed using with pleural diseases (effusion or pneumothorax) or the kappa statistic. -
Antibiotic Prophylaxis to Prevent Surgical Site Infections ALAN R
Antibiotic Prophylaxis to Prevent Surgical Site Infections ALAN R. SALKIND, MD, and KAVITHA C. RAO, MD, University of Missouri–Kansas City School of Medicine Surgical site infections are the most common nosocomial infections in surgical patients, accounting for approxi- mately 500,000 infections annually. Surgical site infections also account for nearly 4 million excess hospital days annually, and nearly $2 billion in increased health care costs. To reduce the burden of these infections, a partner- ship of national organizations, including the Centers for Medicare and Medicaid Services and the Centers for Dis- ease Control and Prevention, created the Surgical Care Improvement Project and developed six infection prevention measures. Of these, three core measures contain recommendations regarding selection of prophylactic antibiotic, timing of administration, and duration of therapy. For most patients undergoing clean-contaminated surgeries (e.g., cardiothoracic, gastrointestinal, orthopedic, vascular, gynecologic), a cephalosporin is the recommended prophylac- tic antibiotic. Hospital compliance with infection prevention measures is publically reported. Because primary care physicians participate in the pre- and postoperative care of patients, they should be familiar with the Surgical Care Improvement Project recommendations. (Am Fam Physician. 2011;83(5):585-590. Copyright © 2011 American Acad- emy of Family Physicians.) surgical site infection is defined performance measures for the appropriate This clinical content con- as an infection that occurs at or selection, administration, and termina- forms to AAFP criteria for near a surgical incision within tion of prophylactic antibiotics for patients evidence-based continu- 30 days of the procedure or undergoing clean-contaminated surgeries. ing medical education Awithin one year if an implant is left in In 2003, the CDC, CMS, and 10 additional (EB CME). -
Antibiotic Prophylaxis 2017 Update
Distribution Information AAE members may reprint this position statement for distribution to patients or referring dentists. Antibiotic Prophylaxis 2017 Update AAE Quick Reference Guide About This Document This paper is designed to Endocarditis Prophylaxis Recommendations provide scientifically based These recommendations are taken from 2017 American Heart Association and guidance to clinicians American College of Cardiology focused update of the 2014 AHA/ADA Guideline regarding the use of antibiotics for Management of Patients with Valvular Disease (1) and cited by the ADA (2). in endodontic treatment. Thank you to the Special Committee on Antibiotic Use in Prophylaxis against infective endocarditis is reasonable before dental Endodontics: Ashraf F. Fouad, procedures that involve manipulation of gingival tissue, manipulation of the Chair, B. Ellen Byrne, Anibal R. periapical region of teeth, or perforation of the oral mucosa in patients with the Diogenes, Christine M. Sedgley following: and Bruce Y. Cha. In 2017, the AHA and American College of Cardiology (ACC) published ©2017 a focused update (5) to their previous guidelines on the management of valvular heart disease. This reinforced their previous recommendations that AP is reasonable for the subset of patients at increased risk of developing IE and at high risk of experiencing adverse outcomes from IE (5). Their key recommendations were: 1. Prosthetic cardiac valves, including transcatheter-implanted prostheses and homografts. 2. Prosthetic material used for cardiac valve repair, such as annuloplasty rings and chords. 3. Previous IE. 4. Unrepaired cyanotic congenital heart disease or repaired congenital heart disease, with residual shunts or valvular regurgitation at the site of or adjacent to the site of a prosthetic patch or prosthetic device. -
Antibiotic Prophylaxis for Patients After Total Joint Replacement
Antibiotic Prophylaxis for Patients after Total Joint Replacement Information Statement from the American Academy of Orthopapedic Surgeons Antibiotic Prophylaxis for Bacteremia in Patients with Joint Replacements This Information Statement was developed as an educational tool based on the opinion of the authors. Readers are encouraged to consider the information presented and reach their own conclusions. More than 1,000,000 total joint arthroplasties are performed annually in the United States, of which approximately 7 percent are revision procedures.1 Deep infections of total joint replacements usually result in failure of the initial operation and the need for extensive revision, treatment and cost. Due to the use of perioperative antibiotic prophylaxis and other technical advances, deep infection occurring in the immediate postoperative period resulting from intraoperative contamination has been markedly reduced in the past 20 years. Bacteremia from a variety of sources can cause hematogenous seeding of bacteria onto joint implants, both in the early postoperative period and for many years following implantation.2 In addition, bacteremia may occur in the course of normal daily life3-5 and concurrently with dental, urologic and other surgical and medical procedures.5 The analogy of late prosthetic joint infections with infective endocarditis is invalid as the anatomy, blood supply, microorganisms and mechanisms of infection are all different.6 It is likely that bacteremia associated with acute infection in the oral cavity,7,8 skin, respiratory, gastrointestinal and urogenital systems and/or other sites can and do cause late implant infection.8 Practitioners should maintain a high index of suspicion for any change or unusual signs and symptoms (e.g. -
Prevention of Hospital-Acquired Infections World Health Organization
WHO/CDS/CSR/EPH/2002.12 Prevention of hospital-acquired infections A practical guide 2nd edition World Health Organization Department of Communicable Disease, Surveillance and Response This document has been downloaded from the WHO/CSR Web site. The original cover pages and lists of participants are not included. See http://www.who.int/emc for more information. © World Health Organization This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors. The mention of specific companies or specific manufacturers' products does no imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. WHO/CDS/CSR/EPH/2002.12 DISTR: GENERAL ORIGINAL: ENGLISH Prevention of hospital-acquired infections A PRACTICAL GUIDE 2nd edition Editors G. Ducel, Fondation Hygie, Geneva, Switzerland J. Fabry, Université Claude-Bernard, Lyon, France L. Nicolle, University of Manitoba, Winnipeg, Canada Contributors R. Girard, Centre Hospitalier Lyon-Sud, Lyon, France M. Perraud, Hôpital Edouard Herriot, Lyon, France A. Prüss, World Health Organization, Geneva, Switzerland A. Savey, Centre Hospitalier Lyon-Sud, Lyon, France E. Tikhomirov, World Health Organization, Geneva, Switzerland M. Thuriaux, World Health Organization, Geneva, Switzerland P. Vanhems, Université Claude Bernard, Lyon, France WORLD HEALTH ORGANIZATION Acknowledgements The World Health Organization (WHO) wishes to acknowledge the significant support for this work from the United States Agency for International Development (USAID). -
Stauffer's Syndrome
Published online: 2021-06-17 Case Report Stauffer’s Syndrome: A Rare Paraneoplastic Syndrome with Renal Cell Carcinoma Abstract Mayank Jain, An elderly male patient presented with cholestatic jaundice and weight loss. On evaluation, he was Joy Varghese1, found to have left renal mass and hepatomegaly. Diagnosis of Stauffer’s syndrome was confirmed K M based on his clinical history, biochemical evaluation, and liver biopsy. Resolution of jaundice was 2 noted after removal of the renal mass. Muruganandham , Jayanthi Keywords: Cholestasis, jaundice, paraneoplastic, renal Venkataraman Departments of Gastroenterology, 1Hepatology Introduction mild portal fibrosis with hepato canalicular and 2Urology, Gleneagles bilirubinomatosis and lobular inflammation. Nonmetastatic nephrogenic hepatic Global Health City, Chennai, The possibility of cholestatic jaundice due Tamil Nadu, India dysfunction syndrome (Stauffer’s syndrome) to paraneoplastic manifestation of renal cell is a paraneoplastic manifestation that often carcinoma was considered. The patient was appears as the initial clinical presentation managed by therapeutic plasma exchange of renal cell carcinoma, bronchogenic for severe pruritus in the preoperative carcinoma, leiomyosarcoma, and prostate period, and he underwent laparoscopic adenocarcinoma.[1-3] Although jaundice has left radical nephrectomy. The surgical rarely been described with this syndrome, a specimen showed clear cell renal cell few case reports have highlighted a variant carcinoma with perinephric fat, hilar sinus of the syndrome with deep icterus.[4,5] fat, hilar vessels, and ureter free of tumor Case Report invasion (Fuhrman Nuclear Grade II). Postoperatively, he had gradual fall in the A 63-year-old male presented with a history bilirubin values over a period of 4 weeks. of yellowish discoloration of eyes and urine, generalized itching, and weight loss Discussion of 10 kg over last 1 month.